{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T13:22:01Z","timestamp":1783948921451,"version":"3.55.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["canadianjournalofophthalmology.ca","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Ophthalmology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jcjo.2025.09.002","type":"journal-article","created":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T11:29:11Z","timestamp":1759922951000},"page":"366-372","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effectiveness of triamcinolone acetonide injection for upper eyelid retraction and excursion in active thyroid eye disease"],"prefix":"10.1016","volume":"61","author":[{"given":"Chrisha Faye","family":"Habaluyas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1804-9526","authenticated-orcid":false,"given":"Muhammad","family":"Abumanhal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9572-4027","authenticated-orcid":false,"given":"Mayari","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1363-2870","authenticated-orcid":false,"given":"Yasuhiro","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcjo.2025.09.002_bib0001","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4103\/tjo.tjo_57_21","article-title":"Management of eyelid retraction related to thyroid eye disease","volume":"12","author":"Osaki","year":"2022","journal-title":"Taiwan J Ophthalmol"},{"key":"10.1016\/j.jcjo.2025.09.002_bib0002","doi-asserted-by":"crossref","first-page":"548","DOI":"10.4103\/tjo.TJO-D-23-00043","article-title":"Nonsurgical management of upper eyelid retraction in thyroid eye disease","volume":"14","author":"Young","year":"2024","journal-title":"Taiwan J Ophthalmol"},{"key":"10.1016\/j.jcjo.2025.09.002_bib0003","doi-asserted-by":"crossref","first-page":"164","DOI":"10.4103\/IJO.IJO_748_24","article-title":"Management of Graves\u2019 upper eyelid retraction (GUER): a review","volume":"73","author":"Desai","year":"2025","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.jcjo.2025.09.002_bib0004","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1177\/11206721241254405","article-title":"Triamcinolone injection in the treatment of lid retraction for thyroid-associated ophthalmopathy: a systematic review","volume":"35","author":"Badjrai","year":"2025","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.jcjo.2025.09.002_bib0005","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1136\/bjophthalmol-2017-310695","article-title":"Non-surgical treatment for eyelid retraction in thyroid eye disease (TED)","volume":"102","author":"Grisolia","year":"2018","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jcjo.2025.09.002_bib0006","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.2147\/OPTH.S456543","article-title":"Subcutaneous injections of triamcinolone acetonide for upper eyelid retraction and swelling associated with thyroid eye disease: a retrospective case series study","volume":"18","author":"Kozaki","year":"2024","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jcjo.2025.09.002_bib0007","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/ceo.12939","article-title":"Peri-levator palpebrae superioris triamcinolone injection for the treatment of thyroid eye disease-associated upper eyelid retraction","volume":"45","author":"Joos","year":"2017","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.jcjo.2025.09.002_bib0008","doi-asserted-by":"crossref","DOI":"10.3389\/fopht.2024.1388197","article-title":"Sullivan TJ. Percutaneous triamcinolone injection for upper eyelid retraction in thyroid eye disease","volume":"4","author":"Parsons","year":"2024","journal-title":"Front Ophthalmol"},{"key":"10.1016\/j.jcjo.2025.09.002_bib0009","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00417-012-2153-y","article-title":"Treatment of upper eyelid retraction related to thyroid-associated ophthalmopathy using subconjunctival triamcinolone injections","volume":"251","author":"Lee","year":"2013","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jcjo.2025.09.002_bib0010","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1080\/01676830.2025.2475823","article-title":"The von Gr\u00e4fe sign measurement","volume":"44","author":"Guimaraes","year":"2025","journal-title":"Orbit"},{"key":"10.1016\/j.jcjo.2025.09.002_bib0011","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.ophtha.2007.07.027","article-title":"Eyelid retraction, lid lag, lagophthalmos, and von Graefe\u2019s sign quantifying the eyelid features of Graves\u2019 ophthalmopathy","volume":"115","author":"Gaddipati","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2025.09.002_bib0012","article-title":"Observations on the efficacy of two methods for the treatment of upper eyelid retraction in thyroid-associated ophthalmopathy","volume":"2021","author":"Li","year":"2021","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.jcjo.2025.09.002_bib0013","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/IOP.0000000000001120","article-title":"Transconjunctival triamcinolone injection for upper lid retraction in thyroid eye disease\u2014a new injection method","volume":"34","author":"Young","year":"2018","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"10.1016\/j.jcjo.2025.09.002_bib0014","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/IOP.0000000000002810","article-title":"Local betamethasone versus triamcinolone injection in management of thyroid eye disease-related upper eyelid retraction with proptosis","volume":"41","author":"Awad","year":"2025","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"10.1016\/j.jcjo.2025.09.002_bib0015","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1097\/IOP.0000000000002662","article-title":"Peri-levator betamethasone versus triamcinolone injection in management of thyroid eye disease-related upper eyelid retraction without proptosis","volume":"40","author":"Awad","year":"2024","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"10.1016\/j.jcjo.2025.09.002_bib0016","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jcjo.2011.12.005","article-title":"Repeated triamcinolone acetonide injection in the treatment of upper-lid retraction in patients with thyroid-associated ophthalmopathy","volume":"47","author":"Xu","year":"2012","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.jcjo.2025.09.002_bib0017","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1097\/SCS.0b013e3182646043","article-title":"Subconjunctival injection of triamcinolone for the treatment of upper lid retraction associated with thyroid eye disease","volume":"23","author":"Lee","year":"2012","journal-title":"J Craniofac Surg"},{"key":"10.1016\/j.jcjo.2025.09.002_bib0018","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/sj.eye.6702933","article-title":"Subconjunctival injection of triamcinolone in the treatment of lid retraction of patients with thyroid eye disease: A case series","volume":"22","author":"Chee","year":"2008","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.jcjo.2025.09.002_bib0019","doi-asserted-by":"crossref","first-page":"5103","DOI":"10.1038\/s41598-025-89063-4","article-title":"Triamcinoline acetonide and botulinum toxin A for upper eyelid retraction in thyroid-associated ophthalmopathy","volume":"15","author":"Huang","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcjo.2025.09.002_bib0020","first-page":"2031","article-title":"Peribulbar injection of glucocorticoids for thyroid-associated ophthalmopathy and factors affecting therapeutic effectiveness: a retrospective cohort study of 386 cases","volume":"20","author":"Wang","year":"2020","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.jcjo.2025.09.002_bib0021","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/IOP.0b013e3181b8e08d","article-title":"Levator excursion as a predictor of both eyelid lad and lagophthalmos in thyroid eye disease","volume":"26","author":"Lelli","year":"2010","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"10.1016\/j.jcjo.2025.09.002_bib0022","doi-asserted-by":"crossref","first-page":"6876","DOI":"10.3390\/jcm12216876","article-title":"Surgical outcomes of bilateral inferior rectus muscle recession for restrictive strabismus secondary to thyroid eye disease","volume":"12","author":"Someda","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.jcjo.2025.09.002_bib0023","unstructured":"Feroze KB, Zeppieri M, Khazaeni L. Steroid-induced glaucoma. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK430903\/. Accessed on 2025 August 9."},{"key":"10.1016\/j.jcjo.2025.09.002_bib0024","doi-asserted-by":"crossref","first-page":"33","DOI":"10.5005\/jp-journals-10008-1013","article-title":"Steroid-induced glaucoma","volume":"3","author":"Dada","year":"2009","journal-title":"J Curr Glaucoma Practice"},{"key":"10.1016\/j.jcjo.2025.09.002_bib0025","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1136\/bjo.73.8.639","article-title":"Clinical criteria for the assessment of disease activity in Graves\u2019 ophthalmopathy: a novel approach","volume":"73","author":"Mourits","year":"1989","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jcjo.2025.09.002_bib0026","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s00417-022-05827-y","article-title":"Risk factors for development of superior limbic keratoconjunctivitis in thyroid eye disease in Japanese","volume":"261","author":"Takahashi","year":"2023","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jcjo.2025.09.002_bib0027","first-page":"325","article-title":"Clinical efficacy of transcutaneous triamcinolone acetonide injection for upper eyelid retraction and swelling in patients with thyroid eye disease","volume":"11","author":"Kozaki","year":"2018","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jcjo.2025.09.002_bib0028","doi-asserted-by":"crossref","first-page":"561","DOI":"10.4103\/ijo.IJO_2228_21","article-title":"Triamcinolone acetonide injection in the treatment of upper eyelid retraction in Graves\u2019 ophthalmopathy evaluated by 3.0 Tesla magnetic resonance imaging","volume":"70","author":"Duan","year":"2022","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.jcjo.2025.09.002_bib0029","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1007\/s00417-015-2957-7","article-title":"Fornix triamcinolone injection for thyroid orbitopathy: a pilot study","volume":"253","author":"Hamed-Azzam","year":"2015","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jcjo.2025.09.002_bib0030","first-page":"142","article-title":"The effects of Graves' eye disease on levator muscle function","volume":"17","author":"Frueh","year":"1986","journal-title":"Ophthalmic Surg"},{"key":"10.1016\/j.jcjo.2025.09.002_bib0031","doi-asserted-by":"crossref","first-page":"721","DOI":"10.2147\/OPTH.S105096","article-title":"Relationship between magnetic resonance imaging signal intensity and volume of extraocular muscles in thyroid-associated ophthalmopathy with methylprednisolone pulse therapy","volume":"10","author":"Higashiyama","year":"2016","journal-title":"Clin Ophthalmol"}],"container-title":["Canadian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008418225003825?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008418225003825?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:49:22Z","timestamp":1775695762000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008418225003825"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S0008418225003825"],"URL":"https:\/\/doi.org\/10.1016\/j.jcjo.2025.09.002","relation":{},"ISSN":["0008-4182"],"issn-type":[{"value":"0008-4182","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness of triamcinolone acetonide injection for upper eyelid retraction and excursion in active thyroid eye disease","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcjo.2025.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Canadian Ophthalmological Society. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}